Generative AI For Effective Drug Design
Our platform uses generative AI to help you speed up your molecule discovery and save your R&D cost by >50%
Virtual screening? Revive project? Patent is outdated? Optimizing properties? antibody, ADC, PROTAC?
Ainnocence harnesses generative artificial intelligence system to deliver advanced analytics to underpin scientific decision making. Our platform offers one of the most accurate and efficient molecule design systems available on the market up to date backed by billions of proprietary datasets. It gives you larger screening spaces and results 10000 times faster than any competition can match without modeling 3D structures. We offers tremendous computational power and unparalleled value to every phase of your small and large molecule drug discovery project from hit identification to lead optimization.
Why Ainnocence?
Faster Delivery
1 week
Accurate Results
80% success rate
Secure Data
AWS Cloud
Animal Free
Humanized Design
Cost Effective
Green AI
Patentable
Expand Patent Space
Our Sponsors
Our platform is build for speed and reliability
Our Clients
Our Service is Versatile and High Quality
News Release:
Ainnocence Embraces Green AI and Animal-Free Drug Screening: A Dual Commitment to Sustainable and Ethical Innovation
AI-Powered Fast and Cost-Effective Antibody De Novo Design and Affinity Maturation Service Unveiled
AI-Driven Broad Neutralization Antibody Design
Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform
The Wall Street Journal Interview with our Founder
ChatGPT in Biology Podcast